Enhanced stimulus-secretion coupling in polyamine-depleted rat insulinoma cells. An effect involving increased cytoplasmic Ca2+, inositol phosphate generation, and phorbol ester sensitivity

A Sjöholm, P Arkhammar, N Welsh, K Bokvist, P Rorsman, A Hallberg, T Nilsson, M Welsh, P O Berggren, A Sjöholm, P Arkhammar, N Welsh, K Bokvist, P Rorsman, A Hallberg, T Nilsson, M Welsh, P O Berggren

Abstract

To extend previous observations on the role of polyamines in insulin production, metabolism, and replication of insulin-secreting pancreatic beta cells, we have studied the role of polyamines in the regulation of the stimulus-secretion coupling of clonal rat insulinoma cells (RINm5F). For this purpose, RINm5F cells were partially depleted in their polyamine contents by use of the specific ornithine decarboxylase inhibitor difluoromethylornithine (DFMO), which led to an increase in cellular insulin and ATP contents. Analysis of different parts of the signal transduction pathway revealed that insulin secretion and the increase in cytoplasmic free Ca2+ concentration ([Ca2+]i) after K(+)-induced depolarization were markedly enhanced in DFMO-treated cells. These effects were paralleled by increased voltage-activated Ca2+ currents, as judged by whole-cell patch-clamp analysis, probably reflecting increased channel activity rather than elevated number of channels per cell. DFMO treatment also rendered phospholipase C in these cells more sensitive to the muscarinic receptor agonist carbamylcholine, as evidenced by enhanced generation of inositol phosphates, increase in [Ca2+]i and insulin secretion, despite an unaltered ligand binding to muscarinic receptors and lack of effect on protein kinase C activity. In addition, the tumor promoter 12-O-tetradecanoylphorbol 13-acetate, at concentrations suggested to be specific for protein kinase C activation, evoked an increased insulin output in polyamine-deprived cells compared to control cells. The stimulatory effects of glucose or the cyclic AMP raising agent theophylline on insulin release were not increased by DFMO treatment. In spite of increased binding of sulfonylurea in DFMO-treated cells, there was no secretory response or altered increase in [Ca2+]i in response to the drug in these cells. It is concluded that partial polyamine depletion sensitizes the stimulus-secretion coupling at multiple levels in the insulinoma cells, including increased voltage-dependent Ca2+ influx and enhanced responsiveness to activators of phospholipase C and protein kinase C. In their entirety, our present results indicate that the behavior of the stimulus-secretion coupling of polyamine-depleted RINm5F insulinoma cells changes towards that of native beta cells, thus improving the usefulness of this cell line for studies of beta cell insulin secretion.

References

    1. Endocrinology. 1991 Jun;128(6):3277-82
    1. J Biol Chem. 1958 Jul;233(1):184-8
    1. FEBS Lett. 1991 Dec 9;294(3):257-60
    1. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):584-8
    1. Am J Physiol. 1992 Feb;262(2 Pt 1):C391-5
    1. Nature. 1970 Aug 15;227(5259):680-5
    1. Anal Biochem. 1971 Jan;39(1):197-201
    1. Diabetologia. 1972 Aug;8(4):260-6
    1. Endocrinology. 1975 Aug;97(2):392-8
    1. Biochim Biophys Acta. 1980;595(1):15-30
    1. Biochemistry. 1979 Nov 27;18(24):5294-9
    1. Pflugers Arch. 1981 Aug;391(2):85-100
    1. Physiol Rev. 1981 Oct;61(4):914-73
    1. J Biol Chem. 1983 Apr 25;258(8):4876-82
    1. Biochem J. 1983 Feb 15;210(2):345-52
    1. Mol Cell Biol. 1983 May;3(5):787-95
    1. Biochem J. 1983 May 15;212(2):473-82
    1. Methods Enzymol. 1983;94:10-25
    1. Anal Biochem. 1983 Dec;135(2):453-5
    1. Nature. 1984 Apr 19-25;308(5961):693-8
    1. Nature. 1984 Nov 29-Dec 5;312(5993):446-8
    1. Biochem J. 1984 Dec 1;224(2):483-90
    1. Proc Natl Acad Sci U S A. 1986 May;83(9):2822-6
    1. Am J Physiol. 1986 May;250(5 Pt 1):G698-708
    1. Biochim Biophys Acta. 1986 Jul 11;887(2):236-41
    1. Med Biol. 1986;64(2-3):89-94
    1. Pflugers Arch. 1986 Nov;407(5):493-9
    1. Biochem J. 1986 Jul 1;237(1):131-8
    1. Biochem J. 1986 Aug 15;238(1):43-7
    1. Cancer Res. 1988 Feb 15;48(4):759-74
    1. Biochem J. 1987 Dec 1;248(2):329-36
    1. J Gen Physiol. 1988 May;91(5):617-39
    1. Biochem J. 1988 Jun 15;252(3):701-7
    1. Biochem J. 1988 Nov 1;255(3):1015-21
    1. Biochem J. 1988 Nov 15;256(1):125-30
    1. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4530-4
    1. Annu Rev Biochem. 1989;58:31-44
    1. Am J Physiol. 1990 Nov;259(5 Pt 1):C828-33
    1. Biochem J. 1990 Oct 15;271(2):393-7
    1. Pancreas. 1990 Nov;5(6):639-46
    1. Am J Physiol. 1991 May;260(5 Pt 1):C1046-51
    1. Eur J Pharmacol. 1992 Feb 13;225(2):167-9
    1. FEBS Lett. 1992 Oct 19;311(2):85-90
    1. Nature. 1993 Jan 28;361(6410):315-25
    1. Biochem J. 1991 Jul 15;277 ( Pt 2):533-40

Source: PubMed

3
Abonner